Related Experiment Video

Updated: Jun 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Other therapies for reducing low-density lipoprotein cholesterol: medications in development

Evan A Stein1

  • 1Metabolic and Atherosclerosis Research Center, 4685 Forest Avenue, Cincinnati, OH, USA. esteinmrl@aol.com

Endocrinology and Metabolism Clinics of North America
|February 17, 2009
PubMed

Insights

Cardiovascular disease remains a leading cause of death globally, despite advances in lipid research and statin drugs. New, effective, and safe lipid-lowering agents are still needed to combat this growing health crisis.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality and morbidity in industrialized nations.
  • Global CVD rates are increasing due to industrialization in countries like India and China.
  • While statins are effective and affordable lipid-lowering drugs, they are not sufficient for all patients.

Purpose of the Study:

  • To review recent advancements in lipid research.
  • To discuss novel therapeutic agents for lipid management.
  • To identify potential new treatments for cardiovascular disease.

Main Methods:

  • Review of current literature on lipid research and cardiovascular disease.
  • Analysis of existing and emerging lipid-lowering drug classes.
  • Discussion of clinical benefits and safety profiles of various agents.

Main Results:

  • Significant progress has been made in understanding lipid metabolism over the past 30 years.
  • Several promising lipid-modulating agents beyond statins have been developed.
  • The need for diverse and safe therapeutic options for CVD remains critical.

Conclusions:

  • Despite advances, cardiovascular disease remains a major global health challenge.
  • Newer lipid-lowering drugs are essential to complement existing therapies like statins.
  • Further research and development are crucial to address unmet needs in CVD prevention and treatment.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...